Cyclooxygenase-2 overexpression has been reported in various human cancers and is associated with poor prognosis in colon carcinoma, pulmonary carcinoma, breast carcinoma, malignant mesothelioma, squamous cell carcinoma, and chronic myelogenous leukemia [14–18]. The gene discussed is PTGS2; the disease is squamous cell carcinoma.